Drug · DIN 02448254
NDUVRA
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since September 25, 2025; first marketed September 25, 2025.
- Drug Identification Number (DIN)
- 02448254
- Company (DIN owner)
- Organon Canada Inc.Kirkland, Quebec, Canada
- Schedule
- Prescription
- Dosage form
- Cream
- Route
- Topical
- Therapeutic class (ATC)
- Tapinarof D05AX07
- Class
- Human
- Record last updated
- September 17, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| TAPINAROF | 1 % | W/W |
Notices of Compliance
Health Canada approvals that name this DIN.
- September 3, 2025: NOC 35953New Drug Submission (NDS) · Administrative: Merger/Buy-out
- April 4, 2025: NOC 35126New Drug Submission (NDS)